| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/29/2005 | US6872850 Inhibiting secretion of proteins encoded by adenosine uridylate-rich messenger RNAs, e.g. tumor necrosis factor, interleukin, interferon, cyclooxygenase-1 and -2 by administering a mono- or bisguanylhydrazones |
| 03/29/2005 | US6872826 Reacting protected heterocyclic amines in the presence of bases and solvents, to form chemical intermeadiates used as chemokine receptor antagonists |
| 03/29/2005 | US6872741 Sodium channel modulators |
| 03/29/2005 | US6872381 Such as 1-(5-chloro-2-(2-((2R)-4-(4-fluoro-18F-benzyl)-2-methylpiperazin-1-yl)-2 -oxoethoxy)phenyl)urea for binding chemokine receptors in brain tissue; tomography |
| 03/29/2005 | CA2241362C Compositions and processes for treating subterranean formations |
| 03/24/2005 | WO2005027157A2 Salt fusible at ordinary temperature and electrochemical device |
| 03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
| 03/24/2005 | WO2005000775A3 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 03/24/2005 | WO2004089922A3 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 03/24/2005 | WO2004073619A3 Ccr8 antagonists |
| 03/24/2005 | WO2004039795A3 Amide compounds for the treatment of hyperlipidemia |
| 03/24/2005 | WO2003079970A8 4-(diarylmethyl)-1-piperazinyl derivatives |
| 03/24/2005 | US20050065350 Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 03/24/2005 | US20050065346 anticoagulants; thrombosis; factor x inhibitor |
| 03/24/2005 | US20050065210 Anticholesterol agents; antilipemic agents; arteriosclerosis; cardiovascular disorders; parasiticides; antitumor agents; antiproliferative agents; antidiabetic agents |
| 03/24/2005 | US20050065163 Platelet adenosine diphosphate receptor antagonists |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065095 Antibacterial agents |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/23/2005 | EP1515961A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 03/23/2005 | EP1515944A1 Aspartyl protease inhibitors |
| 03/23/2005 | EP1515941A1 2-naphthamide derivatives |
| 03/23/2005 | EP1515940A2 Aminoalkoxy-functional chalcones |
| 03/23/2005 | EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 03/23/2005 | EP1045832B1 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 03/23/2005 | CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
| 03/23/2005 | CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 03/23/2005 | CN1599606A Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 03/23/2005 | CN1597674A 1, 3-di[N-(2-methoxy) phenyl] piperazine]-1- acetone hydrochloride and its preparation method and application |
| 03/23/2005 | CN1194006C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869951 Such as N-(2-(4-morphoolinyl)ethyl)-N-((4-((4-pentyl-benzoyl)amino)phenyl)sulfonyl) -D-valine; for treatment of osteoarthritis |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023793A2 Direct synthesis of di-heteroatom containing cyclic organic compounds |
| 03/17/2005 | WO2005023790A1 (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid sodium salt |
| 03/17/2005 | WO2005023789A1 Phosphoric acid salt of (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid |
| 03/17/2005 | WO2005023765A1 Method for catalyzing amidation reactions by the presence of co2 |
| 03/17/2005 | WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023242A1 Entry inhibitors of the hiv virus |
| 03/17/2005 | WO2005023183A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| 03/17/2005 | WO2005023182A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/17/2005 | WO2004110418A3 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/17/2005 | US20050059824 Using carbon dioxide; salt formation, hydrolysis |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059713 Antiviral agents for the treatment, preventions, or amelioration of viral infections; for example, 3-Biphenyl-4-yl-(2S)-[(3'-chloro-4'-fluoro-4-hydroxy-biphenyl-3-carbonyl)-amino]-propionic acid methyl ester |
| 03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 03/17/2005 | US20050059705 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants |
| 03/17/2005 | US20050059689 Therapy for stroke, cancer, multiple sclerosis, brain disorders, Parkinson's disease, Huntington's diseasee |
| 03/17/2005 | US20050059668 Substituted acylpiperazine derivatives |
| 03/17/2005 | US20050059655 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
| 03/17/2005 | CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | CA2536975A1 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
| 03/17/2005 | CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/16/2005 | EP1514559A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 03/16/2005 | EP1514544A1 Antiallergic |
| 03/16/2005 | EP1513825A2 Anti tubercular drug: compositions and methods |
| 03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
| 03/16/2005 | EP1355894B1 Amidinophenylalanine derivatives as thrombin inhibitors |
| 03/16/2005 | EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15) |
| 03/16/2005 | EP1032401B1 Method for inhibiting cytokine production by cells |
| 03/16/2005 | EP0874625B1 Indane derivatives for antipsychotic compositions |
| 03/16/2005 | CN1596251A Piperazine derivatives having SST1 antagonistic activity |
| 03/16/2005 | CN1596248A Phenoxy amine compounds and compositions for delivering active agents |
| 03/16/2005 | CN1596113A Method of treating depression with delta receptor agonist compounds |
| 03/16/2005 | CN1192822C Nickel-rhenium catalyst for use in reductive amination process |
| 03/15/2005 | US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics |
| 03/15/2005 | US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm |
| 03/15/2005 | US6867192 Inhibiting eosinophil infiltration into lungs; such as 2-((-2-((2-(2-Benzoylphenoxy)acetyl)amino)-4-methylpentanoyl)-amino)-3-(4 -(((4-((2-phenylacetyl)amino)-1-piperidinyl)-carbonyl)oxy)phenyl)propanoic acid |
| 03/10/2005 | WO2005021525A1 Aryl piperidine amides |
| 03/10/2005 | WO2005021524A1 Process for the preparation of amorphous form of repaglinide |
| 03/10/2005 | WO2005021523A1 Piperazine substituted compounds used as calcium channel blockers |
| 03/10/2005 | WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 03/10/2005 | WO2005021487A1 Cathepsin inhibitors |
| 03/10/2005 | WO2005021486A1 Ester derivative and medicinal use thereof |
| 03/10/2005 | WO2005021051A1 Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | WO2004096795A3 C-fms kinase inhibitors |
| 03/10/2005 | WO2004085661A3 Process to chiral beta-amino acid derivatives |
| 03/10/2005 | WO2004041802A8 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 03/10/2005 | US20050054856 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control |
| 03/10/2005 | US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis |
| 03/10/2005 | US20050054683 Microbiocides; bacteriocides; oxazolidinone compound |
| 03/10/2005 | US20050054679 For therapy of psychiatric and neurological disorders |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | US20050054637 Prophylaxis, therapy cardiovascular disorders |
| 03/10/2005 | US20050054632 Naphthyl compounds, intermediates, compositions, and methods of use |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | US20050054582 Para-amino benzoic acids as integrin antagonists |
| 03/10/2005 | CA2537487A1 Piperazine substituted compounds used as calcium channel blockers |
| 03/10/2005 | CA2536461A1 Aryl piperidine amides |
| 03/10/2005 | CA2535366A1 Cathepsin inhibitors |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1512684A1 use of derivative of para-phenylenediamine substituted by a homopiperidine ring, for the dyeing of keratinous fibres |